Vera Therapeutics, Inc.
NASDAQ:VERA
48.54 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -95.99 | -89.056 | -32.609 | -53.413 | -11.854 |
| Depreciation & Amortization
| -1.862 | -0.846 | 0.176 | 0.251 | 0.509 |
| Deferred Income Tax
| 0.873 | 0 | -1.799 | 1.185 | 0.104 |
| Stock Based Compensation
| 11.493 | 8.887 | 3.012 | 0.331 | 0.263 |
| Change In Working Capital
| -5.869 | 6.747 | 3.511 | 0.123 | 0.516 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0.159 |
| Inventory
| 0 | 0 | 0 | 0 | -0.159 |
| Accounts Payables
| -0.873 | 10.606 | 0.475 | 0.567 | -0.291 |
| Other Working Capital
| -4.996 | -3.859 | 3.036 | -0.444 | 0.807 |
| Other Non Cash Items
| -0.826 | 6.672 | 4.001 | 16.714 | 0.173 |
| Operating Cash Flow
| -92.181 | -67.596 | -23.708 | -34.809 | -10.289 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.063 | -0.062 | 0 | -0.099 | -0.125 |
| Acquisitions Net
| 0.039 | 0.07 | 0.796 | 0.057 | 0 |
| Purchases Of Investments
| -224.93 | -148.49 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 185.562 | 78 | 0 | 0 | 0 |
| Other Investing Activites
| -0.039 | -0.07 | -5 | 0 | 0 |
| Investing Cash Flow
| -39.431 | -70.552 | -4.204 | -0.042 | -0.125 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 108.8 | 82.117 | 51.176 | 79.841 | 0.051 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 49.482 | -6.097 | 7.627 | 5.579 | -0 |
| Financing Cash Flow
| 133.541 | 101.933 | 53.882 | 85.29 | -0.137 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.293 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 2.222 | -36.215 | 25.97 | 50.439 | -10.551 |
| Cash At End Of Period
| 45.681 | 43.752 | 79.967 | 53.997 | 3.558 |